Incannex Healthcare Limited
General ticker "IXHL" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $92.2M (TTM average)
Incannex Healthcare Limited does not follow the US Stock Market performance with the rate: -21.9%.
Estimated limits based on current volatility of 2.7%: low 2.55$, high 2.70$
Factors to consider:
- Earnings expected soon, date: nan
- Total employees count: 12 (+33.3%) as of 2025
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Operating losses, Funding shortfall, Regulatory and compliance, IP protection, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [1.85$, 5.75$]
- 2027-06-30 to 2028-06-29 estimated range: [1.38$, 4.12$]
Short-term IXHL quotes
Long-term IXHL plot with estimates
Financial data
| YTD | 2026-06-30 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $23.03MM |
| Operating Income | $-23.03MM |
| Non-Operating Income | $-0.93MM |
| R&D Expense | $5.21MM |
| Income(Loss) | $-23.96MM |
| Taxes | $-4.66MM |
| Net Income(Loss)* | $-19.30MM |
| Stockholders Equity | $67.37MM |
| Assets | $72.98MM |
| Operating Cash Flow | $-12.87MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $-0.09MM |
| Financing Cash Flow | $65.90MM |
| Earnings Per Share** | $-1.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.